Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions.

J Cell Mol Med · 2017 · PMC5661257 · PMID 28597545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As a contrast, cells treated with cimifugin showed a trend towards higher expression of CLDN‐1 and occludin (Fig. 5 E, F).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.